Apellis Pharmaceuticals, Inc. - COM (APLS)

Q4 2023 13F Holders as of 12/31/2023

Type / Class
Equity / COM
Number of holders
282
Total Shares
113M
Shares change
+824K
Total reported value, excl. options
$6.74B
Value change
+$138M
Put/Call ratio
0.36
Number of buys
127
Number of sells
-134
Price
$59.86
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.